| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6827601 | Schizophrenia Research | 2011 | 5 Pages |
Abstract
The study did not demonstrate clinical benefit of adjunctive artemisinin for schizophrenia symptoms. The finding of reduced levels of antibodies to gliadin in the artemisinin group merits further study.
Keywords
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Faith Dickerson, Cassie Stallings, Crystal Vaughan, Andrea Origoni, Joshana Goga, Sunil Khushalani, Robert Yolken,